Defeating Alzheimer's disease and other dementias: a priority for European science and society
| العنوان: | Defeating Alzheimer's disease and other dementias: a priority for European science and society |
|---|---|
| المؤلفون: | Serge Gauthier, Philippe Amouyel, Martin Knapp, Chengxuan Qiu, Henry Brodaty, Henrik Zetterberg, Gunhild Waldemar, René J. F. Melis, Bengt Winblad, Francesca Mangialasche, Frank Jessen, Caroline Graff, Khalid Iqbal, Marcel G. M. Olde Rikkert, Miia Kivipelto, Lon S. Schneider, Bruno Dubois, Giovanni B. Frisoni, Philip Scheltens, Thomas P. Sakmar, Gunilla Johansson, Sandrine Andrieu, Jean Georges, Linus Jönsson, Clive Ballard, Agneta Nordberg, Carol Brayne, Anders Wimo, Howard Feldman, Lars O. Tjernberg, Laura Fratiglioni, Reisa A. Sperling, David Edvardsson, Angel Cedazo-Minguez |
| المساهمون: | Neurology, Amsterdam Neuroscience - Neurodegeneration |
| المصدر: | Lancet Neurology, 15, 455-532 Lancet Neurology, 15, 5, pp. 455-532 Winblad, B, Amouyel, P, Andrieu, S, Ballard, C, Brayne, C, Brodaty, H, Cedazo-Minguez, A, Dubois, B, Edvardsson, D, Feldman, H, Fratiglioni, L, Frisoni, G B, Gauthier, S, Georges, J, Graff, C, Iqbal, K, Jessen, F, Johansson, G, Jonsson, L, Kivipelto, M, Knapp, M, Mangialasche, F, Melis, R, Nordberg, A, Rikkert, M O, Qiu, C, Sakmar, T P, Scheltens, P, Schneider, L S, Sperling, R, Tjernberg, L O, Waldemar, G, Wimo, A & Zetterberg, H 2016, ' Defeating Alzheimer's disease and other dementias: a priority for European science and society ', Lancet Neurology, vol. 15, no. 5, pp. 455-532 . https://doi.org/10.1016/S1474-4422Test(16)00062-4 The lancet Lancet Neurology, 15(5), 455-532. Lancet Publishing Group The Lancet Neurology, Vol. 15, No 5 (2016) pp. 455-532 The Lancet. Neurology, vol 15, iss 5 ResearcherID |
| سنة النشر: | 2016 |
| مصطلحات موضوعية: | medicine.medical_specialty, Alzheimer`s disease Donders Center for Medical Neuroscience [Radboudumc 1], Biomedical Research, Clinical Sciences, Disease, therapy [Dementia], ddc:616.89, 03 medical and health sciences, 0302 clinical medicine, Quality of life (healthcare), Alzheimer Disease, mental disorders, medicine, Dementia, Humans, ddc:610, 030212 general & internal medicine, Psychiatry, health care economics and organizations, organization & administration [Biomedical Research], Neurology & Neurosurgery, therapy [Alzheimer Disease], economics [Biomedical Research], Neurosciences, medicine.disease, Clinical neurology, Europe, Neurology (clinical), Alzheimer's disease, Psychology, 030217 neurology & neurosurgery |
| الوصف: | Alzheimer's disease (AD) is the leading cause of dementia, and because the primary risk factor for AD is old age, the prevalence of the disease is increasing dramatically with ageing populations worldwide. Even in high-income countries, the cost of medical care and associated societal burdens of dementia threaten to become overwhelming as more people live into old age. In view of the lack of progress in developing a cure for AD and the rapidly increasing costs of dementia, policy makers and governments have a powerful incentive to provide more resources to develop AD therapeutics. The Lancet Neurology Commission was formed with the overarching aim to provide information and expert recommendations to policy makers and political leaders about the growing problem of AD and related dementias of ageing. |
| وصف الملف: | application/pdf |
| تدمد: | 1474-4422 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc43640a67596bd9b77310301afbd2cTest http://hdl.handle.net/2066/167709Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....9cc43640a67596bd9b77310301afbd2c |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14744422 |
|---|